COVID-19 Pandemic Waves and 2024-2025 Winter Season in Relation to Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers and Amantadine

Puigdellívol-Sánchez, Anna; Juanes, Marta; Calderon Valdiviezo, Ana Isabel; Losa, Helena; González Salvador, Marta; Leon, Marc; Pueyo Anton, Luis; Franco-Romero, M; Lozano-Paz, Celia; Cortés Borra, Albert; Valls, Roger

Ver

COVID-19 Pandemic Waves and 2024-2025 Winter Season in Relation to Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers and Amantadine, 2025 (1.084Mb)

Fecha

2025-05-27

Enlace permanente

http://hdl.handle.net/11351/13598

DOI

10.3390/healthcare13111270

ISSN

2227-9032

PMID

40508884

Registro Completo

Palabras clave

Oleadas de COVID-19; Inhibidores de la enzima convertidora de angiotensina; Amantadina

Citación recomendada

Puigdellívol-Sánchez A, Juanes-González M, Calderón-Valdiviezo AI, Losa-Puig H, González-Salvador M, León-Pérez M, et al. COVID-19 Pandemic Waves and 2024-2025 Winter Season in Relation to Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers and Amantadine. Healthcare (Basel). 2025 May 27;13(11):1270.